Another possibility for news is the pre-clinical r
Post# of 157795
temozolmide, at the Albert Einstein College of Medicine, under Pestell's supervision. It was "underway" in March. Since Dr. Jay was suggesting that a third-party-funded study in Glioblastoma is being launched, this must have had good results. The area is so lacking that any good news is big news.

